Bradley Merrill Thompson Quoted in Article, “Mobile Health Groups Say the FDA’s Final Guidance Will ‘Unlock Investment'”

Venture Beat

Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted in an article titled "Mobile Health Groups Say the FDA's Final Guidance Will 'Unlock Investment.'"

Following is an excerpt:

The Food and Drug Administration (FDA) is under pressure to decide how it will regulate mobile health applications. While the FDA demurs on issuing its final guidance over which medical and consumer health apps come under its jurisdiction, developers are operating in a state of confusion.

"The MRC believes the timely release of the final guidance will benefit industry, stimulate investment, help ensure patient safety and is consistent with the views expressed by Congress," MRC representative Bradley Merrill Thompson stated in a two-page letter addressed to Sebelius. Merrill Thompson is an attorney with the Washington-based law office Epstein Becker & Green.

Good news for developers: The MRC is convinced the final guidance will "unlock needed investment" in mobile health and shrink FDA oversight. "Some people mistakenly believe that the final guidance will expand FDA jurisdiction. It will not," Merrill Thompson added.

Note: This article also appeared in MedCity News.